Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 45, 2021 - Issue 1
3,448
Views
13
CrossRef citations to date
0
Altmetric
Review Articles

β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study

ORCID Icon, ORCID Icon, &
Pages 1-4 | Received 10 Sep 2020, Accepted 12 Nov 2020, Published online: 14 Dec 2020
 

Abstract

β-Thalassemia (β-thal) is one of the most common inherited diseases all over the world. These patients are very susceptible to infection disease, and the mortality and morbidity of infected patients will increase. The object of this systematic review study was to determine mortality and morbidity of infected β-thal patients with coronavirus disease 2019 (COVID-19). We searched PubMed, Elsevier, and Scholar Google to obtain related papers. The time of search was 21 June until 17 July 2020. All original and review articles and case reports were searched with key words: COVID 19, beta or β-thalassemia (β-thal), mortality and morbidity. Data were extracted after quality assessment of all articles. We obtained seven, 21 and six articles from PubMed, Scholar Google and Science Direct, respectively. Finally, seven articles were discussed in our study. The total number of enrolled patients was 34. Twenty-six patients carried transfusion-dependent β-thal major (β-TM). The most common symptoms were fever, cough, pain and dyspnea. Nine patients died. The result of this study has shown that the mortality and morbidity of infected β-thal patients will escalate.

Acknowledgments

The authors would like to thank Mr Seyed A. Hashemi (Student at Andishmand High School, Sari, Iran), for helpful language editing. M. Zafari, N. Nikbahki, M.T.S. Rad and F. Mohseni conducted the search strategy, screened and selected the full texts, quality assessment and data extraction.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.